Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa
LEARN MOREShown to be effective against nine causes of clostridial disease in healthy cattle 3 months of age or older.
LEARN MOREUse SHUTOUT® teat sealant to create a physical barrier against mastitis-causing environmental bacteria in dry dairy cows.
LEARN MORE